Introducing patient‐reported outcome in the acute leukemia quality registries in Sweden

Abstract

This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. AbstractObjectives: The use of patient-reported outcome (PRO) measured outside clinical trials is not well defined. We report the first analysis of the prospective PRO study within the Swedish acute myeloid leukemia (AML) and the acute lymphoblastic leukemia (ALL) registries. Methods: PRO was requested 6 months after diagnosis. The EORTC Quality of life Questionnaire Core 30-item, the Patient Health Questionnaire-8 (PHQ-8), and questions from a Swedish National Cancer Questionnaire were used.Results: An invitation letter was sent to 398 patients; 255 (64%) responded, 60% web-based, and 40% on paper. The ALL cohort had lower physical, role and social functioning, higher symptom burden, and more financial difficulties compared to the AML cohort. A PHQ-8 score ≥ 10p, which indicates depression, was reported in 18% of the patients; 33% of these patients reported being prescribed antidepressants. The patients' overall experience of care was satisfying, but more psychological and practical support was desired. There was no difference in survival between patients who reported their PRO and those who did not. Follow-up at 2 and 4 years is ongoing.Conclusions: PRO collected in a registry-based setting is feasible, but the selection of time points and questionnaires are delicate in a diverse patient population.

Survival Outcomes and Health-Related Quality of Life in Older Adults Diagnosed with Acute Myeloid Leukemia Receiving Frontline Therapy in Daily Practice

“…HRQoL evaluation is acquiring increasing importance in the decision-making process in hematologic and solid neoplasms, but there are still barriers to overcome in older adults diagnosed with AML, mainly due to the difficulty of retrieving this type of information from retrospective studies, the still anecdotal presence of HRQoL data in AML registries [45], and the lack of consensus on the best validated specific AML-HRQoL tool [46][47][48]. Fortunately, HRQoL evaluation in comparative trials on older adults with AML has become more frequent in recent times.…”

Quality-adjusted Time Without Symptoms of disease or Toxicity (Q-TWiST) analysis of CPX-351 versus 7 + 3 in older adults with newly diagnosed high-risk/secondary AML

“…The importance of quality-of-life, as well as quantity of life, gained with a novel intervention compared to the older, conventional therapy, is increasingly recognized in cancer management as an important element when evaluating various treatment options, including in patients with AML whose health-related quality-of-life is impaired [15][16][17][18]. For example, a new cancer therapy may prolong survival, but the added time may come predominantly from time spent with serious AEs that negatively affect the quality-of-life of patients.…”

Tripartite prehabilitation of patients with acute myeloid leukaemia and high-risk myelodysplastic syndromes during intensive chemotherapy before allogeneic haematopoietic stem cell transplantation (COHABILIT): protocol for an innovating prospective multicentre study

“…33 Furthermore, developing patients' sense of self-efficacy and self-determination and enhancing their belief on the effects of APA may favour commitment. [34][35][36] Recent data suggest that support such as coaching could enable patients to fulfill their psychological needs and give meaning to their actions, and thereby attain psychological well-being. 37 38 In the field of sport, several studies have established a link between the quality of the coach-athlete relationship and the athlete's well-being.…”